1.
Celesia BM, Marino A, Fontana del Vecchio R, Bruno R, Palermo F, Gussio M, et al. IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?. Mediterr J Hematol Infect Dis [Internet]. 2019 Oct. 30 [cited 2024 Mar. 28];11(1):e2019063. Available from: https://www.mjhid.org/mjhid/article/view/2019.063